Skip to main content
OpenTrials
Completed

NCT Number: NCT00767767

The Effect of Intravenous Anesthetics on Fear Learning and Memory

People often develop fearful responses to things, but have no conscious control over the fear. This is a basic form of unconscious memory, called "fear conditioning." Intravenous anesthetic drugs have remarkable effects on conscious memory, but it is unknown whether they have similar effects on these unconscious fear memories.

To address this question, the investigators will study 114 healthy adult volunteer subjects. The subject is given a very low dose of an anesthetic drug intravenously (i.e. through the bloodstream). The dose is so low that the subject might not even be able tell if they are getting the drug. While they are receiving the drug, the subject will perform a series of memory tests and a fear conditioning experiment, which are set up like a very simple computer game. To create the "fear response", subjects will occasionally receive a mildly uncomfortable shock to their arm. The subject is able to determine the highest level of shock that they will receive.

The investigators are doing this study because the investigators wish to know exactly how the drugs affect the way people process fear and emotion. This knowledge might one day be used in the treatment of some psychiatric disorders.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Weill Cornell Medical College/New York Presbyterian Hospital

New York, 10065, United States

About this study

People often develop fearful responses to things, but have no conscious control over the fear (e.g. phobias). This is a basic form of unconscious memory, called "fear conditioning." Intravenous anesthetic drugs have remarkable effects on conscious memory, but it is unknown whether they have similar effects on these unconscious fear memories.

To address this question, the investigators will study 114 healthy adult volunteer subjects. The subject is given a very low dose of an anesthetic drug intravenously (i.e. through the bloodstream). The dose is so low that the subject might not even be able tell if they are getting the drug. While they are receiving the drug, the subject will perform a series of memory tests and a fear conditioning experiment, which are set up like a very simple computer game. To create the "fear response", subjects will occasionally receive a mildly uncomfortable shock to their arm. The subject is able to determine the highest level of shock that they will receive.

The investigators are doing this study because the investigators wish to know exactly how the drugs affect the way people process fear and emotion. This knowledge might one day be used in the treatment of some psychiatric disorders.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age between 18 and 50
  • minimum of high school education
  • fluent in English
  • normal vocabulary

Exclusion criteria

  • any significant medical or psychiatric comorbidity (e.g. asthma, diabetes, hypertension, depression, high anxiety)--subjects must be in excellent health such that they would be classified as American Society of Anesthesiologists Physical Status Class I
  • deficit in vision or hearing that would impede the study
  • allergies to any of the study drugs, to soybeans, or to eggs
  • a history of head trauma
  • a family history of major psychiatric illness
  • body mass index > 30 kg/m2
  • a recent history of recreational drug use
  • prior exposure to the study materials
  • pregnancy
  • a personal or family history of any porphyria
  • failure to exhibit a skin conductance response to deep inspiration
  • the ability to read Chinese characters
  • assessment by the investigators that the subject may be unable to cooperate or comply with the study requirements.

Treatment and study plan

Placebos

Drug

IV Saline infusion for 2 hours.

Propofol 0.45mcg/mL

Drug

IV Propofol infusion for 2 hours.

Other names: Propofol

Propofol 0.90mcg/mL

Drug

IV Propofol infusion for 2 hours.

Other names: Propofol

Thiopental 1.5mcg/mL

Drug

IV Thiopental 1.5mcg/mL infusion for 2 hours

Other names: Thiopental

Thiopental 3mcg/mL

Drug

IV Thiopental 3mcg/mL infusion for 2 hours

Other names: Thiopental

Primary outcomes

  1. GSR Trial 1

    Time frame: First Trial, for up to 1 day

    Galvanic skin repose (GSR) to the first habituation trial (yes/no). Coding: Yes (0) and No (1)

Sponsors and collaborators

Lead sponsor

Weill Medical College of Cornell University

Other

Collaborators

  • National Institute of General Medical Sciences (NIGMS)
  • National Institutes of Health (NIH)

Registry information

Important dates

Study start
2008
Primary completion
2011
Study completion
2011
First posted
Oct 7, 2008
Registry last updated
May 15, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.